🇺🇸 FDA
Company

AEON

AEON Biopharma

AEON biotech USA

Quick answer

AEON is a biotech company (AEON) headquartered in IRVINE, CA, USA with 9 tracked pipeline programs.

Pipeline (9)

project

ABP-450

Cervical Dystonia

Phase 2 · small_molecule · completed

2 trials project

ABP-450

Migraine

Phase 2 · small_molecule · terminated

2 trials project

Mitomycin C

Glaucoma

Phase 2 · small_molecule · completed

1 trials project

Provisc

Steroid Induced Glaucoma

Phase 2 · small_molecule · completed

1 trials project

ET1402L1-ARTEMIS™ T cells -IV

Hepatocellular Carcinoma

Phase 1 · mab · completed

1 trials project

Ologen Collagen Matrix

Congenital Glaucoma

Phase 1 · other · active

1 trials project

autologous ET1402L1-CART cells

Hepatocellular Carcinoma

Phase 1 · mab · terminated

1 trials project

Use of Mitomycin-C (MMC) in trabeculectomy

Glaucoma

Approved · small_molecule · completed

1 trials project

Use of Mitomycin-C in trabeculectomy

Open-angle Glaucoma

Unknown · small_molecule · active

1 trials

Patents (8)

patent

US 11911455

HPV therapeutic nucleic acid vaccine

Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11826405

Neurotoxin compositions for use in treating headache

Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9901606

Euglena lysate composition

Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9274109

Gut flora-derived extracellular vesicles, and method for searching for a disease

Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9201072

Gut flora-derived extracellular vesicles, and method for searching for a disease

Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9149542

Microvesicles derived from cell protoplast and use thereof

Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9084830

Microvesicles derived from cell protoplast and use thereof

Expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 8969653

Extracellular vesicles derived from gram-positive bacteria, and use thereof

Expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)